Clinical Trials Browser

Phase 1 × Ototoxicity × Clear all

NCT04262336 2023-07-06

Study to Evaluate Safety and Efficacy of DB-020 to Protect Hearing in Patients Receiving Cisplatin for Cancer Treatment

Phase 1 Completed

Ototoxicity, Hearing Loss